Eric Pauwels

Companies

• PTC TherapeuticsChief Business Officer Apr 17, 2020 to now¹
• PTC TherapeuticsChief executive officer Apr 19, 2024 to Feb 21, 2025²
• PTC TherapeuticsBoard member Apr 19, 2024 to Apr 19, 2024²
• NPS Pharmaceuticals (United States)President May 7, 2014 to Feb 24, 2015³
• NPS Pharmaceuticals (United States)Chief Commercial Officer Sep 27, 2011 to Feb 14, 2014⁴
• NPS Pharmaceuticals (United States)Chief operating officer Oct 19, 2011 to Oct 19, 2011⁵
• ACCURAY INCSVP Chief Marketing Officer Jan 27, 2011 to Mar 1, 2011⁶

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• PTC Therapeutics PTCT73,411 shares⁷$4.5M at $60.99Jun 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jun 10, 2026Sold 17,566 shares at $75.00 of PTC Therapeutics⁷
• Jun 10, 2026Exercised options 17,566 shares at $18.01 of PTC Therapeutics⁷
• Jun 10, 2026Sold 3,711 shares at $75.00 of PTC Therapeutics⁷
• Feb 18, 2026Sold 3,019 shares at $69.36 of PTC Therapeutics⁸
• Jan 12, 2026Sold 1,024 shares at $78.70 of PTC Therapeutics⁹
• Jan 9, 2026Sold 1,722 shares at $77.41 of PTC Therapeutics⁹
• Jan 8, 2026Sold 1,454 shares at $76.45 of PTC Therapeutics⁹
• Jan 8, 2026Sold 587 shares at $76.98 of PTC Therapeutics⁹
• Jan 8, 2026Sold 2,561 shares at $76.42 of PTC Therapeutics⁹
• Jan 7, 2026Sold 1,352 shares at $77.48 of PTC Therapeutics¹⁰
• Jan 6, 2026Sold 1,789 shares at $76.95 of PTC Therapeutics¹⁰
• Jan 2, 2026Granted 20,000 shares of PTC Therapeutics¹¹
• Dec 19, 2025Sold 3,220 shares at $78.33 of PTC Therapeutics¹²
• Dec 19, 2025Sold 10,548 shares at $77.55 of PTC Therapeutics¹²
• Dec 19, 2025Sold 4,537 shares at $76.33 of PTC Therapeutics¹²
• Dec 19, 2025Sold 1,500 shares at $75.77 of PTC Therapeutics¹²
• Dec 19, 2025Exercised options 19,805 shares at $66.49 of PTC Therapeutics¹²
• Dec 19, 2025Sold 59 shares at $78.43 of PTC Therapeutics¹²
• Dec 19, 2025Sold 313 shares at $77.73 of PTC Therapeutics¹²
• Dec 19, 2025Sold 193 shares at $75.45 of PTC Therapeutics¹²
• Dec 19, 2025Exercised options 565 shares at $18.01 of PTC Therapeutics¹²
• Dec 19, 2025Sold 59 shares at $78.01 of PTC Therapeutics¹²
• Dec 19, 2025Sold 42 shares at $77.26 of PTC Therapeutics¹²
• Dec 19, 2025Sold 37 shares at $75.66 of PTC Therapeutics¹²
• Dec 19, 2025Exercised options 138 shares at $66.49 of PTC Therapeutics¹²